• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives Chlorinated biphenyls

3-(3-Chloro-4-methoxycarbonylphenyl)phenol: A Comprehensive Overview of CAS No. 1261944-48-2

3-(3-Chloro-4-methoxycarbonylphenyl)phenol (CAS No. 1261944-48-2) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique 3-chloro-4-methoxycarbonylphenyl substituent, exhibits a range of biological activities that make it a valuable candidate for various applications, including drug discovery and development.

The molecular structure of 3-(3-Chloro-4-methoxycarbonylphenyl)phenol consists of a phenolic ring attached to a substituted benzene ring. The presence of the chloro and methoxycarbonyl groups imparts specific chemical properties and reactivity patterns, which are crucial for its biological activity. These functional groups contribute to the compound's ability to interact with various biological targets, making it a subject of extensive study in both academic and industrial settings.

Recent research has highlighted the potential of 3-(3-Chloro-4-methoxycarbonylphenyl)phenol in the treatment of several diseases. For instance, studies have shown that this compound possesses anti-inflammatory properties, which could be beneficial in managing conditions such as arthritis and other inflammatory disorders. The mechanism of action involves the inhibition of pro-inflammatory cytokines and enzymes, thereby reducing inflammation and associated pain.

In addition to its anti-inflammatory effects, 3-(3-Chloro-4-methoxycarbonylphenyl)phenol has also demonstrated promising antioxidant activity. Antioxidants play a crucial role in neutralizing free radicals, which are known to cause cellular damage and contribute to various diseases, including cancer and neurodegenerative disorders. The phenolic hydroxyl group in the molecule is particularly effective in scavenging free radicals, making it a potential therapeutic agent for oxidative stress-related conditions.

The pharmacokinetic properties of 3-(3-Chloro-4-methoxycarbonylphenyl)phenol have been extensively studied to understand its behavior in biological systems. Research indicates that the compound has good oral bioavailability and is rapidly absorbed into the bloodstream. It also exhibits favorable distribution and metabolism profiles, which are essential for its therapeutic efficacy. However, further studies are needed to optimize its pharmacokinetic parameters and enhance its therapeutic potential.

Clinical trials involving 3-(3-Chloro-4-methoxycarbonylphenyl)phenol are currently underway to evaluate its safety and efficacy in human subjects. Preliminary results from phase I trials have shown that the compound is well-tolerated at therapeutic doses, with minimal side effects. These findings are encouraging and pave the way for more advanced clinical trials to explore its potential as a novel therapeutic agent.

The synthetic route for producing 3-(3-Chloro-4-methoxycarbonylphenyl)phenol is well-established and involves several steps, including the formation of the substituted benzene ring and the introduction of the phenolic group. The process can be optimized to achieve high yields and purity, making it suitable for large-scale production in pharmaceutical settings.

In conclusion, 3-(3-Chloro-4-methoxycarbonylphenyl)phenol (CAS No. 1261944-48-2) is a promising compound with a wide range of biological activities. Its anti-inflammatory and antioxidant properties make it a valuable candidate for drug development, particularly in the treatment of inflammatory diseases and oxidative stress-related conditions. Ongoing research and clinical trials will further elucidate its therapeutic potential and pave the way for its use as a novel therapeutic agent.

• 247092-10-0(Methyl 2-chloro-5-hydroxybenzoate)
• 1261898-37-6(5-(4-Chloro-3-methoxycarbonylphenyl)-2-formylphenol)
• 1261899-94-8(3-(4-Chloro-3-methoxycarbonylphenyl)-5-hydroxybenzoic acid)
• 1261944-63-1(Methyl 2-chloro-5-(4-chloro-3-hydroxyphenyl)benzoate)
• 1261916-51-1(3-(4-Chloro-3-methoxycarbonylphenyl)phenol)
• 1261935-84-5(3-(4-Chloro-3-methoxycarbonylphenyl)-5-methoxybenzoic acid)
• 1261935-04-9(4-(4-Chloro-3-methoxycarbonylphenyl)-2-methylphenol)
• 1261944-41-5(3-(2-Chloro-5-methoxycarbonylphenyl)phenol)
• 1261944-59-5(4-(3-Chloro-4-methoxycarbonylphenyl)phenol)
• 1261944-49-3(2-Chloro-5-(3-chloro-4-methoxycarbonylphenyl)phenol)